GFBiochemicals Wins John Sime Award for Most Innovative New Technology


At the European Forum for Industrial Biotechnology and the Bioeconomy (EFIB) in Brussels today, GFBiochemicals was presented with the John Sime award by DSM Board member Stephan Tanda. GFBiochemicals is the first company to produce levulinic acid at commercial scale directly from biomass.

The John Sime award is given each year to the best presentation of the most innovative new technology presented in the Innovation Track at EFIB. This year for the first time, the audience voted. The award is dedicated to John Sime, who played a pivotal role in the early development of EFIB.

Founded in 2008, GFBiochemicals uses breakthrough technology to commercialize GF Biochemicalslevulinic acid – a valuable biobased building block for specialty chemicals and materials. The company has offices in Milan, Italy and Geleen, the Netherlands. GFBiochemicals’ Chief Commercial Officer Marcel van Berkel's presentation on ‘Making levulinic acid happen’ outlined how GFBiochemicals is producing levulinic acid direct from biomass at its 10,000 MT/a capacity commercial-scale production plant in Caserta, Italy. This will make a fundamentally lower price range possible, said Van Berkel, using the unique technology because production is direct from biomass without intermediate process steps. This will allow the development of new applications and markets.

On receiving the award, Marcel van Berkel thanked EFIB and said, “We are both honored and humbled to receive this endorsement from our peers in the industry.”(KL)